Zusammenfassung
Hintergrund
Studien haben gezeigt, dass die atriale Überstimulation bzw. Optimierung der interatrialen Leitungszeit die Vorhofflimmerlast reduzieren kann. Eine vermehrte ventrikuläre Stimulation erhöht die Inzidenz von Vorhofflimmern (AF).
Patienten und Methode
Bei 25 Patienten mit paroxysmalem AF wurde ein Zweikammerschrittmacher (Identity DR 5370, Fa. St. Jude Medical) implantiert. Nach Randomisierung wurde die atriale Elektrode entweder septal (n=12) oder lateral/Herzohr (n=13) platziert, die atriale Überstimulation (DAO) aktiviert und die AV-Zeit nach Koglek optimiert. Nach 3, 6, 9 und 12 Monaten wurde der Mode-Switch-Anteil (Vorhofflimmerlast) erfasst.
Ergebnisse
Es traten keine signifikant verlängerten Implantationszeiten der septalen Sonde auf. Die technischen Implantationsparameter lagen für beide Gruppen im Normbereich. Nach 12 Monaten zeigte sich eine geringere Vorhofflimmerlast in der septal stimulierten Gruppe (1% vs. 7%; p=0,06), wobei auch die Gesamtzahl der AF-Episoden septal geringer war.
Schlussfolgerung
Die septale Vorhofstimulation ist sicher. In Kombination mit DAO und optimierter AV-Zeit führt sie zu einer Reduktion der Vorhofflimmerlast, welche sich nach 12 Monaten abzeichnet.
Abstract
Background
Atrial overdrive and optimized interatrial conduction time can reduce atrial fibrillation (AF). Increased ventricular stimulation results in a higher incidence of atrial fibrillation.
Patients and methods
In 25 patients with paroxysmal AF, a dual-chamber pacemaker (Identity DR 5370, St. Jude Medical) was implanted. Atrial leads were placed randomly either septal (n=12) or conventional (n=13). Dynamic atrial overdrive (DAO) was activated and the AV delay was optimized according to Koglek’s method. After 3, 6, 9, and 12 months automatic mode switch (AF burden) was analysed.
Results
No difference in implantation parameters were observed between groups. Technical implantation parameters were in the normal range for both groups. After 12 months patients in the septal group had less AF burden (1% vs. 7%, p=0.06), and the total number of AF episodes was reduced.
Conclusion
Septal pacing is safe. In combination with DAO and AV delay optimization it may reduce the AF burden, which can be observed after 12 months.
Literatur
Ausma J, van der Velden HM, Lenders MH et al (2003) Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 107:2051–2058
Bailin SJ, Adler S, Giudici M (2001) Prevention of chronic atrial fibrillation by pacing in the region of Bachmann’s bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol 12:912–917
Blanc JJ, De Roy L, Mansourati J, PIPAF Investigators et al (2004) Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 6:371–379
Carlson MD, Ip J, Messenger J, ADOPT Investigators et al (2003) A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 42:627–633
De Voogt WG, de Vusser P, Lau CP, on behalf of the OASES Study Group et al (2003) OASES trial: Overdrive atrial septal stimulation in patients with paroxysmal atrial fibrillation and class 1 and class 2 pacemaker indication. NASPE Late Breaking Clinical Trials (http://www.naspe.oscsi.com)
Ellenbogen KA, Thames MD, Mohanty PK (1990) New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculo-atrial pacing. Am J Cardiol 65:53–59
Funck RC, Adamec R, Lurje L, PROVE Study Group et al (2000) Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE Study. Pacing Clin Electrophysiol 23:1891–1893
Ismer B, von Knorre GH, Voss W, Placke J (2004) Approximation of the individual optimal AV delay using left atrial electrocardiography. Herzschrittmacherther Elektrophysiol 15:I/33–I/38
Israel CW, Hügl B, Unterberg C, AT500 Verification Study Investigators et al (2001) Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 12:1121–1128
Kannel WB, Abbott RD, Savage DD et al (1982) Epidemiologic features of chronic atrial fibrillation. The Framingham Study. N Engl J Med 306:1018–1022
Koglek W, Kranig W, Kowalski M et al (2000) Eine einfache Methode zur Bestimmung des AV-Intervalls bei Zweikammerschrittmachern. Herzschrittmacherther Elektrophysiol 11:244–253
Lam CT, Lau CP, Leung SK et al (2000) Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation. Europace 2:286–291
Lewalter T, Yang A, Bielik H et al (2002) Atrial fibrillation: stimulation and pacemaker therapy. Herz 27:345–356
Lewalter T, Yang A, Pfeiffer D et al (2006) Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry. Pacing Clin Electrophysiol 29:124–134
Ovsyshcher IE (1997) Toward physiological pacing: optimization of cardiac hemodynamics by AV delay adjustment. Pacing Clin Electrophysiol 20:861–865
Padeletti L, Pürerfellner H, Adler SW, for the Worldwide ASPECT Investigators et al (2003) Combined efficiacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrythmia. J Cardiovasc Electrophysiol 14:1189–1195
Padeletti L, Pieragnoli P, Ciapetti C et al (2001) Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 142:1047–1055
Padeletti L, Porciani MC, Michelucci A et al (1999) Interatrial septum pacing: A new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol 3:35–43
Papageorgiou P, Anselme F, Kirchhof CJ et al (1997) Coronary sinus pacing prevents induction of atrial fibrillation. Circulation 96(6):1893–1898
Raitt MH, Kusumoto W, Giraud G, McAnulty JH (2004) Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 1:507–512
Schuchert A, Rebeski HP, Peiffer T, 3:4 Study Group et al (2008) Effects of continuous and triggered atrial overdrive pacing on paroxysmal atrial fibrillation in pacemaker patients. Pacing Clin Electrophysiol 31:929–934
Sparks PB, Mond HG, Vohra JK et al (1999a) Electrical remodeling of the atrial following loss of atrioventricular synchrony. A long-term study in humans. Circulation 100:1894–1900
Sparks PB, Mond HG, Vohra JK et al (1999b) Mechanical remodeling of the atrial following loss of atrioventricular synchrony. A long-term study in humans. Circulation 100:1714–1721
Sulke N, Silberbauer J, Boodhoo L et al (2007) The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study. Europace 9:790–797
Sweeney MO, Hellkamp AS, Ellenbogen KA, MOde Selection Trial Investigators et al (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klein, M., Klein, N. & Pfeiffer, D. Atriale Stimulation zur Prävention von Vorhofflimmern. Herzschr. Elektrophys. 20, 148–153 (2009). https://doi.org/10.1007/s00399-009-0057-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00399-009-0057-2
Schlüsselwörter
- Vorhofflimmern
- Herzschrittmacher
- AV-Delay-Optimierung
- Septale Stimulation
- Präventive Stimulationsalgorithmen